XML 41 R15.htm IDEA: XBRL DOCUMENT v3.21.2

Revenue (Tables)

6 Months Ended

Jun. 30, 2021

Revenue

Schedule of revenue by type and collaboration partner under agreements

​

​	​	​	​	​
​		6 Months Ended		6 Months Ended
​	​	June 30, 2021	​	June 30, 2020
(DKK million)	​	​	​	​
Revenue by type:		​
Royalties		2,595		1,738
Reimbursement revenue		227		175
Milestone revenue		731		32
License revenue		—		4,398
​	​	​	​	​
Total		3,553		6,343
​	​	​	​	​
Revenue by collaboration partner:		​		​
Janssen		2,846		1,652
AbbVie		245		4,398
Roche	​	162	​	83
Seagen	​	56	​	99
BioNTech	​	171	​	76
Novartis	​	73	​	9
Other collaboration partners		—		26
​	​	​	​	​
Total		3,553		6,343

X

- References

No definition available.

+ Details

Name:	gmab_ResultsForYearAbstract
Namespace Prefix:	gmab_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2020-01-01
-Paragraph 114
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2020-en-r&anchor=para_114&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration